Credit Suisse’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $3.6M | Sell |
101,654
-6,353
| -6% | -$254K | ﹤0.01% | 1486 |
|
|
2023
Q4 | $4.7M | Buy |
108,007
+9,770
| +10% | +$384K | ﹤0.01% | 1368 |
|
|
2023
Q3 | $3.75M | Sell |
98,237
-1,705
| -2% | -$71.7K | ﹤0.01% | 1439 |
|
|
2023
Q2 | $4.11M | Buy |
99,942
+6,701
| +7% | +$323K | ﹤0.01% | 1465 |
|
|
2023
Q1 | $5.35M | Buy |
93,241
+5,495
| +6% | +$310K | 0.01% | 1258 |
|
|
2022
Q4 | $4.92M | Buy |
87,746
+19,348
| +28% | +$985K | 0.01% | 1315 |
|
|
2022
Q3 | $2.9M | Buy |
68,398
+3,463
| +5% | +$177K | ﹤0.01% | 1603 |
|
|
2022
Q2 | $3.51M | Sell |
64,935
-3,087
| -5% | -$185K | ﹤0.01% | 1533 |
|
|
2022
Q1 | $4.37M | Buy |
68,022
+6,212
| +10% | +$409K | ﹤0.01% | 1552 |
|
|
2021
Q4 | $4.14M | Sell |
61,810
-10,039
| -14% | -$679K | ﹤0.01% | 2179 |
|
|
2021
Q3 | $4.92M | Buy |
71,849
+2,373
| +3% | +$168K | ﹤0.01% | 2083 |
|
|
2021
Q2 | $4.74M | Sell |
69,476
-10,508
| -13% | -$743K | ﹤0.01% | 2125 |
|
|
2021
Q1 | $5.53M | Buy |
79,984
+4,698
| +6% | +$318K | ﹤0.01% | 1996 |
|
|
2020
Q4 | $4.89M | Sell |
75,286
-64,406
| -46% | -$3.47M | ﹤0.01% | 2110 |
|
|
2020
Q3 | $6.6M | Sell |
139,692
-9,681
| -6% | -$461K | ﹤0.01% | 1622 |
|
|
2020
Q2 | $7.02M | Sell |
149,373
-3,359
| -2% | -$165K | 0.01% | 1494 |
|
|
2020
Q1 | $6.82M | Buy |
152,732
+74,007
| +94% | +$3.88M | 0.01% | 1372 |
|
|
2019
Q4 | $4.59M | Sell |
78,725
-16,558
| -17% | -$986K | ﹤0.01% | 1941 |
|
|
2019
Q3 | $5.72M | Sell |
95,283
-27,273
| -22% | -$1.62M | ﹤0.01% | 1652 |
|
|
2019
Q2 | $6.84M | Buy |
122,556
+61,495
| +101% | +$3.17M | 0.01% | 1544 |
|
|
2019
Q1 | $3.4M | Buy |
61,061
+17,910
| +42% | +$912K | ﹤0.01% | 1998 |
|
|
2018
Q4 | $1.95M | Sell |
43,151
-13,707
| -24% | -$752K | ﹤0.01% | 2263 |
|
|
2018
Q3 | $3.75M | Buy |
56,858
+9,309
| +20% | +$579K | ﹤0.01% | 1897 |
|
|
2018
Q2 | $3.06M | Sell |
47,549
-14,722
| -24% | -$912K | ﹤0.01% | 2110 |
|
|
2018
Q1 | $3.44M | Sell |
62,271
-24,983
| -29% | -$1.31M | ﹤0.01% | 1984 |
|
|
2017
Q4 | $4.17M | Sell |
87,254
-1,363
| -2% | -$66.7K | ﹤0.01% | 1901 |
|
|
2017
Q3 | $4.47M | Sell |
88,617
-121,279
| -58% | -$6.23M | ﹤0.01% | 1848 |
|
|
2017
Q2 | $11.4M | Sell |
209,896
-34,897
| -14% | -$1.67M | 0.01% | 1124 |
|
|
2017
Q1 | $10.3M | Buy |
244,793
+175,067
| +251% | +$7.48M | 0.01% | 1203 |
|
|
2016
Q4 | $2.99M | Sell |
69,726
-6,396
| -8% | -$260K | ﹤0.01% | 2102 |
|
|
2016
Q3 | $3.14M | Buy |
76,122
+14,576
| +24% | +$611K | ﹤0.01% | 2028 |
|
|
2016
Q2 | $2.46M | Buy |
61,546
+23,216
| +61% | +$835K | ﹤0.01% | 2177 |
|
|
2016
Q1 | $1.29M | Sell |
38,330
-1,974
| -5% | -$61.5K | ﹤0.01% | 2533 |
|
|
2015
Q4 | $1.37M | Buy |
40,304
+1,530
| +4% | +$47.8K | ﹤0.01% | 2565 |
|
|
2015
Q3 | $1.15M | Sell |
38,774
-87,349
| -69% | -$2.73M | ﹤0.01% | 2698 |
|
|
2015
Q2 | $3.47M | Buy |
126,123
+96,102
| +320% | +$2.56M | ﹤0.01% | 2071 |
|
|
2015
Q1 | $757K | Buy |
30,021
+3,169
| +12% | +$74.9K | ﹤0.01% | 3212 |
|
|
2014
Q4 | $595K | Sell |
26,852
-2,626
| -9% | -$53.2K | ﹤0.01% | 3570 |
|
|
2014
Q3 | $598K | Sell |
29,478
-11,102
| -27% | -$221K | ﹤0.01% | 3505 |
|
|
2014
Q2 | $781K | Buy |
40,580
+7,834
| +24% | +$146K | ﹤0.01% | 3505 |
|
|
2014
Q1 | $615K | Sell |
32,746
-16,269
| -33% | -$314K | ﹤0.01% | 3552 |
|
|
2013
Q4 | $957K | Buy |
49,015
+10,302
| +27% | +$189K | ﹤0.01% | 3315 |
|
|
2013
Q3 | $637K | Buy |
+38,713
| New | +$621K | ﹤0.01% | 3336 |
|
Other funds holding IART
CB
CIP
Credit Suisse's IART Position: Q1 2024 in Review
Credit Suisse reduced its Integra LifeSciences (IART) stake by 5.9% in Q1 2024, selling an estimated $254K and leaving 101,654 shares worth $3.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1486.
Credit Suisse first reported a position in IART in Q3 2013 and has held it in 43 quarters since. The position peaked at $11.4M in Q2 2017. 281 funds tracked by Wall St. Rank hold IART as of Q1 2024.
- Credit Suisse held 101,654 shares of Integra LifeSciences worth $3.6M as of Q1 2024.
- Credit Suisse sold 6,353 Integra LifeSciences shares in Q1 2024, an estimated $254K.
- Integra LifeSciences made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1486 holding.
- Credit Suisse first reported a position in Integra LifeSciences in Q3 2013 and has held it in 43 quarters since.
- Credit Suisse's Integra LifeSciences position peaked at $11.4M in Q2 2017.
- 281 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.